NPTX
Price:
$0.0003
Market Cap:
$28.14K
Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neurop...[Read more]
Industry
Biotechnology
IPO Date
2019-12-05
Stock Exchange
OTC
Ticker
NPTX
According to Neuropathix, Inc.’s latest financial reports and current stock price. The company's current ROE is 111.19%. This represents a change of 348.24% compared to the average of 24.81% of the last 4 quarters.
The mean historical ROE of Neuropathix, Inc. over the last ten years is 123.63%. The current 111.19% ROE has changed -10.07% with respect to the historical average. Over the past ten years (40 quarters), NPTX's ROE was at its highest in in the June 2019 quarter at 273.15%. The ROE was at its lowest in in the December 2015 quarter at -451.89%.
Average
123.63%
Median
100.14%
Minimum
45.97%
Maximum
269.52%
Discovering the peaks and valleys of Neuropathix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 284.56%
Maximum Annual ROE = 269.52%
Minimum Annual Increase = -62.14%
Minimum Annual ROE = 45.97%
| Year | ROE | Change |
|---|---|---|
| 2021 | 100.14% | -42.56% |
| 2020 | 174.34% | -35.31% |
| 2019 | 269.52% | 284.56% |
| 2018 | 70.08% | 52.45% |
| 2017 | 45.97% | -62.14% |
| 2016 | 121.42% | 44.64% |
The current ROE of Neuropathix, Inc. (NPTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
181.33%
5-year avg
132.01%
10-year avg
123.63%
Neuropathix, Inc.’s ROE is less than Humanigen, Inc. (0%), greater than Total Brain Limited (-104.70%), less than Cantabio Pharmaceuticals, Inc. (0%), less than Sensyne Health plc (0%), less than QSAM Biosciences, Inc. (1.62%), less than NeonMind Biosciences Inc. (366.65%), greater than Diagnocure, Inc. (-110.73%), less than NMC Health plc (20.78%), less than Generex Biotechnology Corporation (216.76%), less than Navidea Biopharmaceuticals, Inc. (355.34%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $23.82K | |
| -104.70% | $26.74K | |
| 0% | $22.77K | |
| 0% | $33.29K | |
| 1.62% | $18.44K | |
| 366.65% | $8.54K | |
| -110.73% | $21.52K | |
| 20.78% | $2.09K | |
| 216.76% | $0 | |
| 355.34% | $10.01K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuropathix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuropathix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Neuropathix, Inc.'s ROE?
How is the ROE calculated for Neuropathix, Inc. (NPTX)?
What is the highest ROE for Neuropathix, Inc. (NPTX)?
What is the 3-year average ROE for Neuropathix, Inc. (NPTX)?
What is the 5-year average ROE for Neuropathix, Inc. (NPTX)?
How does the current ROE for Neuropathix, Inc. (NPTX) compare to its historical average?